Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARNI in Advanced Lung Cancer with Concurrent Hypertension
NCT07261098Phase 2Not yet recruiting
- Sponsor
- Shanghai Chest Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sacubitril + valsartan in hypertension (HTN), sponsored by Shanghai Chest Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07261098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07261098.